(Q39377749)

English

Patients with peritoneal mesothelioma lack epidermal growth factor receptor tyrosine kinase mutations that would make them sensitive to tyrosine kinase inhibitors

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22426987%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Patients with peritoneal mesothelioma lack epidermal growth factor receptor tyrosine kinase mutations that would make them sensitive to tyrosine kinase inhibitors (English)

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22426987%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

0 references

peritoneal mesothelioma

1 reference

based on heuristic

inferred from title

author name string

Neetu Kalra

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22426987%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Ali Ashai

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22426987%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Liqiang Xi

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22426987%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Jingli Zhang

4

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22426987%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Itzhak Avital

5

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22426987%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Mark Raffeld

6

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22426987%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Raffit Hassan

7

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22426987%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

publication date

15 March 2012

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22426987%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Oncology Reports

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22426987%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

27

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22426987%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

6

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22426987%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

1794-1800

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22426987%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

describes a project that uses

0 references

0 references

0 references

0 references

0 references

0 references

Epidermal growth factor receptor dependence in human tumors: more than just expression?

1 reference

https://pubmed.ncbi.nlm.nih.gov/22426987

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22426987

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diffuse malignant mesothelioma of the peritoneum and pleura, analysis of markers

1 reference

https://pubmed.ncbi.nlm.nih.gov/22426987

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

1 reference

https://pubmed.ncbi.nlm.nih.gov/22426987

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mutations and addiction to EGFR: the Achilles 'heal' of lung cancers?

1 reference

https://pubmed.ncbi.nlm.nih.gov/22426987

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gefitinib in patients with malignant mesothelioma: a phase II study by the Cancer and Leukemia Group B.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22426987

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Erlotinib in previously treated non-small-cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22426987

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Common EGFR mutations conferring sensitivity to gefitinib in lung adenocarcinoma are not prevalent in human malignant mesothelioma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22426987

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Advances in malignant mesothelioma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22426987

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

EGFR overexpression in malignant pleural mesothelioma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22426987

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidermal growth factor receptor (EGFR) is highly conserved in pancreatic cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22426987

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mutation and polymorphism in the EGFR-TK domain associated with lung cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22426987

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of erlotinib in patients with malignant pleural mesothelioma: a Southwest Oncology Group Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22426987

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Involvement of EGFR in the response of squamous cell carcinoma of the head and neck cell lines to gefitinib

1 reference

https://pubmed.ncbi.nlm.nih.gov/22426987

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidermal growth factor receptor gene mutation, amplification and protein expression in malignant pleural mesothelioma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22426987

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Specific EGFR mutations predict treatment outcome of stage IIIB/IV patients with chemotherapy-naive non-small-cell lung cancer receiving first-line gefitinib monotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22426987

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

EGFR polymorphism of the kinase domain in Japanese lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22426987

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Novel and existing mutations in the tyrosine kinase domain of the epidermal growth factor receptor are predictors of optimal resectability in malignant peritoneal mesothelioma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22426987

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular characterization of EGFR, PDGFRA and VEGFR2 in cervical adenosquamous carcinoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22426987

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Time trend of mesothelioma incidence in the United States and projection of future cases: an update based on SEER data for 1973 through 2005.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22426987

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22426987

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidermal growth factor receptor in relation to tumor development: EGFR gene and cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22426987

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Receptor tyrosine kinase and downstream signalling analysis in diffuse malignant peritoneal mesothelioma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22426987

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical implications of novel activating EGFR mutations in malignant peritoneal mesothelioma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22426987

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification of G2607A mutation in EGFR gene with a significative rate in Moroccan patients with nasopharyngeal carcinoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22426987

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diffuse malignant peritoneal mesothelioma: systematic review of clinical management and biological research

1 reference

https://pubmed.ncbi.nlm.nih.gov/22426987

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidermal growth factor receptor mutation in gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22426987

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

EGFR and KRAS mutations in Chinese patients with adenosquamous carcinoma of the lung

1 reference

https://pubmed.ncbi.nlm.nih.gov/22426987

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.3892/OR.2012.1725

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22426987%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22426987%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22426987%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39377749&oldid=1823558347"